The essential drugs concept is needed now more than ever

Area of Science:

• Public Health
• Health Policy
• Pharmaceutical Policy

Background:

• The concept of essential medicines, established in the 1970s-1980s, is resurfacing on the international health policy agenda.
• The Essential Drugs List (EDL) is a cornerstone of national drug policies in 146 countries, prioritizing public health relevance, efficacy, safety, and cost.
• Current concerns link the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement to potential impacts on access to essential medicines.

Purpose of the Study:

• To review the concept of essential medicines within the evolving political landscape.
• To analyze the implications of international agreements on the accessibility of essential drugs.
• To advocate for continued support of the Essential Drugs List as a critical public policy instrument.

Main Methods:

• Literature review of the essential medicines concept and its historical context.
• Analysis of the current international health policy agenda and relevant agreements.
• Examination of the role and impact of the Essential Drugs List (EDL).

Main Results:

• The essential medicines debate has been reignited due to concerns over access, particularly in light of intellectual property agreements.
• The Essential Drugs List (EDL) is a widely adopted and crucial tool for ensuring rational drug selection based on public health needs.
• The political context surrounding essential medicines has shifted, necessitating a re-evaluation of access strategies.

Conclusions:

• The Essential Drugs List (EDL) is a fundamental public policy tool that requires sustained support in all nations.
• Addressing concerns related to intellectual property rights is essential for safeguarding access to essential medicines.
• Continued international dialogue and policy development are necessary to ensure equitable access to medicines globally.